Morbidity and All-Cause Mortality Following Radical Prostatectomy Compared with Observation for Localized Prostate Cancer in Chinese Men: A Non-Randomized Retrospective Study

22 February 2021 : Clinical Research

Xi Zhang^1ABF, Xiang Li^1ABF, Qiwei Yu^1BDF, Jun Ma^1CDF, Xuemin Zeng^1BCF, Li Xue^2DEF*

DOI: 10.12659/MSM.928596

Med Sci Monit 2021; 27:e928596

Table 3 Risk factor for all-cause mortality.

Men died in the follow-up	291
Characteristics at the time of diagnosing	Odd ratio	95% confidence limit	p-Value
Age (≥65-year vs^*	2.451	0.451–0.982	0.041
Prostate specific antigen level (>10 ng/mL vs ≤10 ng/mL)	1.052	0.681–0.941	0.053
Charlson score (≥1 vs 0)	0.893	0.611–0.872	0.098
Gleason score (≥7 vs^*	1.151	0.511–0.852	0.049
Tumor stage (≥2c vs tumor stage ≤2b)^*	1.892	0.482–0.912	0.045
CAPRA scores (high vs low and intermediate)	1.031	0.512–0.895	0.058
Multivariate analysis. Data of survived men (n=119) were considered the reference standard. Odd ratio >1 and -value ^* Significant risk factor associated with all-cause mortality. CAPRA scores – Cancer of Prostate Risk Assessment scores.